Invention Grant
- Patent Title: GLP-1 receptor agonists and uses thereof
-
Application No.: US16220184Application Date: 2018-12-14
-
Publication No.: US10669259B2Publication Date: 2020-06-02
- Inventor: Gary Erik Aspnes , Scott W. Bagley , John M. Curto , Matthew S. Dowling , David Edmonds , Mark E. Flanagan , Kentaro Futatsugi , David A. Griffith , Kim Huard , Gajendra Ingle , Wenhua Jiao , Chris Limberakis , Alan M. Mathiowetz , David W. Piotrowski , Roger B. Ruggeri
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Feng Shao
- Main IPC: A61K31/496
- IPC: A61K31/496 ; A61K31/4545 ; C07D401/14 ; C07D487/04 ; A61P3/00 ; A61P15/10 ; A61P17/06 ; A61P9/10 ; A61P19/06 ; A61P25/28 ; A61P25/30 ; A61P43/00 ; A61P1/16 ; A61P25/02 ; A61P3/04 ; A61P19/02 ; A61P3/10 ; A61P13/12 ; A61P25/18 ; A61P1/00 ; A61P15/00 ; A61P25/16 ; C07D405/14 ; C07D413/14 ; C07D471/04
Abstract:
Provided herein are 6-carboxylic acids of benzimidazoles and 4-aza-, 5-aza-, 7-aza- and 4,7-diaza-benzimidazoles as GLP-1R agonists, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.
Public/Granted literature
- US20190119255A1 GLP-1 Receptor Agonists and Uses Thereof Public/Granted day:2019-04-25
Information query
IPC分类:
